Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Angelo Auricchio , Anne B Curtis Added: 4 months ago
Prof Anne Curtis (University of Buffalo, US) and Prof Angelo Auricchio (Fondazione Cardiocentro Ticino, CH) discuss contemporary clinical data of Implantable Cardioverter Defibrillators (ICDs) from real world populations. The discussion is focused on the importance and impact of ICD therapy on prevention of sudden cardiac death by analysing the latest presented data.In context, the data analysed… View more
Author(s): Joshua R Silverstein , Demosthenes G Katritsis , Mark E Josephson Added: 3 years ago
Sudden cardiac death (SCD) is one of the leading causes of death in developed countries. The yearly incidence of SCD is estimated to be 3,000,000 worldwide and between 300,000–450,000 in both the US and Western Europe.1,2 The survival rate for SCD is <1 % worldwide and close to 5 % in the developed world.3 In the past, cardiac arrest was thought to be most commonly due to ventricular… View more
Author(s): Deepika Narasimha , Anne B Curtis Added: 3 years ago
Implantable cardiac devices such as implantable cardioverter- defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices lead to improved survival and better clinical outcomes in appropriately selected patients with heart failure (HF) with a reduced ejection fraction (EF). Although there are significant sex differences in the aetiology, pathophysiology and clinical course of HF,… View more
Author(s): Andrei D Mărgulescu , Mark H Anderson Added: 3 years ago
Motor vehicle travel and driving has become a major component of daily living in the developed world. Sudden incapacity occurring while driving can result in accidents that may be fatal both for the driver and for bystanders. The regulatory approach aims to balance the risk to bystanders against the highly valued individual freedom of motorised mobility. In this article we review some of the… View more
Author(s): Pier D Lambiase Added: 2 years ago
Prof Pier Lambiase (UCL & Barts Heart Centre, London, UK) discusses the long-term efficacy and final outcomes of the subcutaneous implantable cardioverter-defibrillator (S-ICD) registry. The registry was conducted at 50 centres worldwide, in patients requiring an ICD for the treatment of ventricular tachyarrhythmias. Questions 1. What are the benefits of S-ICDs compared to ICDs? 2. What is the S… View more
Author(s): Charles D Swerdlow Added: 3 years ago
Balanced Evaluation of the ICD Although better known for his transformative contributions to arrhythmia mechanisms, mapping and ablation, Dr Josephson participated in investigational studies of the first implantable defibrillator2,3 and served as a principal investigator for the MUSTT (Multicenter Unsustained Tachycardia Trial) foundational trial of primary-prevention ICD therapy.4 In one of the… View more
Job title: Cardiac Physiologist
Matthew Swift is the lead Cardiac Physiologist for CRM at the Great Western Hospital, Swindon. His professional interests include the optimisation of CRT devices, programming ICDs and improving the patient experience while increasing patient safety. View more